| Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study (NCT02324595) | Catholic University of the Sacred Heart | 2013-12-01 |
| Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01670799) | New Mexico Cancer Research Alliance | 2012-03-01 |
| Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT01137071) | Recepta Biopharma | 2011-04-01 |
| A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer (NCT01281514) | Fox Chase Cancer Center | 2010-12-14 |
| Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer (NCT01166737) | AGO Study Group | 2010-07-01 |
| Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer (NCT00993655) | Canadian Cancer Trials Group | 2010-03-03 |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor (NCT01096381) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 (NCT01074398) | Gynecologic Oncology Group | 2010-02-01 |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity (NCT00825201) | City of Hope Medical Center | 2009-01-01 |
| Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers (NCT00803569) | Ludwig Institute for Cancer Research | 2008-11-14 |
| Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer (NCT00652899) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies (NCT00625092) | Masonic Cancer Center, University of Minnesota | 2007-10-01 |
| Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer (NCT00702299) | University of Arizona | 2007-09-01 |
| Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00748527) | Cancer Research UK | 2007-07-01 |
| Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00536523) | University of Minnesota | 2007-04-01 |
| Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin (NCT00436644) | Mayo Clinic | 2007-03-01 |
| Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy (NCT00466960) | University of Washington | 2006-05-01 |
| Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin (NCT00369954) | Gynecologic Oncology Group | 2006-04-01 |
| Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer (NCT00354601) | Wake Forest University Health Sciences | 2006-01-01 |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00331422) | Masonic Cancer Center, University of Minnesota | 2005-10-01 |
| Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer (NCT00357448) | University of Washington | 2005-04-01 |
| Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00112957) | Ludwig Institute for Cancer Research | 2004-12-01 |
| Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer (NCT00030706) | Montefiore Medical Center | 2004-11-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer (NCT00101257) | Fred Hutchinson Cancer Center | 2004-10-01 |
| Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00287859) | Masonic Cancer Center, University of Minnesota | 2004-08-01 |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer (NCT00217529) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer (NCT00245050) | Case Comprehensive Cancer Center | 2004-04-01 |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer (NCT00287885) | Masonic Cancer Center, University of Minnesota | 2004-03-01 |
| Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer (NCT00227721) | Robert Morris | 2004-02-01 |
| Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00538031) | City of Hope Medical Center | 2003-12-22 |
| Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma (NCT00653328) | Vanderbilt-Ingram Cancer Center | 2003-05-01 |
| S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer (NCT00043082) | SWOG Cancer Research Network | 2002-08-01 |
| PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00085384) | M.D. Anderson Cancer Center | 2002-07-01 |
| Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00217555) | Fred Hutchinson Cancer Center | 2002-07-01 |
| Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00897806) | M.D. Anderson Cancer Center | 2002-02-01 |
| Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00028743) | NCIC Clinical Trials Group | 2001-08-31 |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer (NCT00008138) | SWOG Cancer Research Network | 2001-03-01 |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00550784) | City of Hope Medical Center | 2001-01-01 |
| Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer (NCT00010179) | NCIC Clinical Trials Group | 2000-10-31 |
| Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00006391) | NYU Langone Health | 2000-08-01 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery (NCT00004895) | Northwestern University | 1999-10-01 |
| Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer (NCT00004081) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer (NCT00003450) | University of Texas Southwestern Medical Center | 1998-09-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003944) | Fox Chase Cancer Center | 1998-08-01 |
| Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (NCT00652691) | Mayo Clinic | 1998-08-01 |
| S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission (NCT00003120) | SWOG Cancer Research Network | 1997-11-01 |
| Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (NCT00005049) | NYU Langone Health | 1997-05-01 |